Table 1.
Patient # | Approx Age at Examinationa | Phenotype | Gene | Exonic function | AAChange | Chr | Co-ordinate (Hg19) | Other info | ACMG classification system | Comment | Other reports of same variant |
---|---|---|---|---|---|---|---|---|---|---|---|
43 | Less than 5 years old | Feeding problems and failure to thrive, global developmental delay, Autism. Height 25%ile, weight -3SD, OFC 2-10%ile. CT/MRI-Dysgenesis of the corpus callosum. | ARID1B | Frame-shift single base deletion | NM_017519:c.1595delG:p.G532fs | 6 | 157150413 | het | PVS1, PS2, PM2 = Pathogenic | Sufficient to cause disease | |
58 | Less than 5 years old | Developmental delay. Subtle growth difference involving whole left side. Height 75%ile, weight 25%ile, OFC 66th %ile. MRI- hemimegancephaly and hypertrophy on one side. Mild dilation of lateral ventricles, mildly smaller left hemisphere with suggestion of pachygyria near anterior temple lobes. | PHF6 | Stop gain SNV | NM_001015877:c.C820T:p.R274a | X | 133549136 | het | PVS1, PS2, PM2, PP3 = pathogenic | Sufficient to cause disease | COSM144567, COSM1134629 |
59 | Between 10 and 15 years old | Moderate developmental delay, facial dysmporphisms, seizure reported at 12 years. Enlarged labia. Self-abusive when angry. Height <25%ile, weight between 50th and 75th %ile. OFC 25th %ile. CT- mild ventriculomegaly. | SPRY4 | Nonsynonymous SNV | NM_001127496:c.T508A:p.C170S | 5 | 141694166 | het | PS2, PM2, PP3 = Likely pathogenic | Possibly contributory to brain phenotype | |
AP4E1 | Nonsynonymous SNV |
NM_001252127.1:c.T3140C:p.L1047P NM_007347.4:c.T3365C:p.L1122P |
15 | 51294810 | het | N/A | N/A | ||||
AP4E1 | Splice-donor SNV |
NM_001252127.1:c.121 + 2 T > C NM_007347.4:c.346 + 2 T > C |
15 | 51207770 | het | N/A | N/A | ||||
45 | Between 10 and 15 years old | Developmental delay and visual inattentiveness noted at 3 months. Athetoid movements with dystonic posturing present by 15 months and seizures noted by 2 years of age. At age four, a diagnosis of autism was suspected but could not be confirmed given the severe to profound ID. MRI: thin corpus callosum, increased ventricle and subarachnoid space size. | CACNB3 | Nonsynonymous SNV | NM_001206915:c.G1289A:p.R430Q | 12 | 49221639 | het | PS2, PP3 = Uncertain significance | May play a role in the brain morphological phenotype | |
SCN3A | Nonsynonymous SNV | NM_006922.3:c.T626C:p.L209P | 2 | 166020196 | het | N/A | Selected as candidate for epilepsy phenotype. Functional studies underway | ||||
51b | Between 15 and 20 years old | Significant intellectual disability. Gross motor delay. Seizuring. Scoliosis. Some hearing deficiency. Astigmatism and far-sightedness. Remarkable family history. Pregnancy complicated by possible oligohydramnios. Suctioned for meconium and physically stimulated. Placenta was calcified. MRI- asymmetrical lateral ventricles. | SQSTM1 | Two base indel, causing a stop-gain | NM_003900: c.115_116delinsTA:p.A39a | 5 | 179248051-179248052 | het | PS2, PM2, PP3 = Likely pathogenic | Unsure of relative contribution of this variant versus others in the same child | |
UPF1 | Two base indel causing a mis-sense mutation | NM_002911: c.1576_1577delinsAA:p.A526N | 19 | 18966765 - 18966766 | het | PS2, PM2, PP3 = Likely pathogenic | Unsure of relative contribution of this variant versus others in the same child | ||||
42 | Less than 5 years old. | Recurrent aspiration. Optic nerve dysfunction detected by absence of light reflex. Height, weight and OFC all at 25%ile. CT- absence of corpus callosum. | LRP2 | Nonsynonymous SNV | NM_004525.2:c.G4351T:p.V1451F | 2 | 170094756 | het | N/A | N/A | |
LRP2 | Nonsynonymous SNV | NM_004525.2:c.A12725G:p.D4242G | 2 | 170003335 | het | N/A | N/A | ||||
41 | CT- cerebellar atrophy | ||||||||||
55 | CT- mild dilation of the lateral ventricles |
Abbreviations: ID Intellectual Disability, OFC occipito-frontal circumference, CT computerized tomography scan, MRI magnetic resonance imaging scan, PVS1 null variant in a gene where LoF is a known mechanism of disease, PS2 de novo in a patient with the disease and no family history, PM2 absent from controls in exome sequencing project, 1000 genomes project or exome aggregation consortium, PP3 multiple lines of computational evidence support a deleterious effect on the gene or gene product
aAge at examination is given in 5 year intervals in order to protect patient anonymity
bPatient 51 also bears a de novo likely contributory CNV as detailed in the text, in addition to the SNVs given here